You can buy or sell IVERIC and other stocks, options, ETFs, and crypto commission-free!
IVERIC bio, Inc. Common Stock, also called IVERIC, is a biopharmaceutical company which engages in discovering, developing, and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Read More Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Oct 30, Pre-Market